Treatment outcome by subset of efavirenz concentration windows in studies 266-003/004/005/021/024
C24 ɛ.5 µM C24 ?3.5 µM Total
Failure 17 (63%) 20 (21%) 37 (30%)
Non-Failure 10 (37%) 77 (79%) 87 (70%)
These data show that treatment failure was three times as frequent (63% versus 21%) when EFV C24 ɛ.5 µM
Joshi, 39 ICAAC, San Francisco, 1999, abstract 1201